Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Eli Lilly and Company
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male and female patients between the ages of 18 and 65 years (inclusive)
Subjects must meet the DSM-IV criteria for schizophrenia, schizoaffective disorder, or schizophreniform disorder
Subjects must have been treated with olanzapine (5 to 20 mg/day) for at least 12 weeks prior to study entry and who experienced a weight gain of greater than or equal to 7% of body weight during olanzapine treatment
You may not be if
Treatment with an injectable depot neuroleptic 14 days before visit 1
Subjects with an PANSS score greater than 70
One or more seizures without a clear and unresolved etiology
Known diagnosis of DSM-IV substance dependence (except nicotine and caffeine) within the past 2 months, which in the opinion of the investigator is affecting the diet and/or weight of the subject
As a result of liver function test, ALT/AST ranges are shown twice the upper limit of the normal reference range
